Cambi: Q3 Orders Up, Dividend Approved Despite Revenue Dip
Cambi ASA announced third-quarter 2025 revenues of NOK 257m, down from NOK 277m in Q3 2024, yet maintained positive operating cash flow. EBITDA for the quarter stood at NOK 42m, compared to NOK 68m last year. The quarter's strong performance was highlighted by an impressive order intake of NOK 422m, a substantial increase from NOK 117m in Q3 2024, largely due to a new biosolids handling contract for Grønn Vekst and the inclusion of CNP Cycles' projects following a majority stake acquisition.
The company's order backlog increased to NOK 1,103m, up from the previous quarter, though still lower than NOK 1,324m a year ago. Approximately 60% of this backlog is expected to be delivered by 2026, with a significant portion in 2025. Cambi's chief executive, Per Lillebø, noted stable project execution and progress in rolling out new thermal hydrolysis models, Model E and Model P.
Cambi's board of directors approved an additional dividend of NOK 0.45 per share, bringing the total distributions for 2025 to NOK 0.75 per share, representing approximately 80% of the 2024 net profit. The company will host a webcast on November 6 to discuss these results further.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Cambi ASA publishes news
Free account required • Unsubscribe anytime